{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Elsholtzia ciliata", "MAPKs", "apoptosis", "glutamate", "osmundacetone (OAC)", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33671577", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "23"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "22"}], "Language": ["eng"], "ELocationID": ["328", "10.3390/biom11020328"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "11", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "22"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Protective Effect of Osmundacetone against Neurological Cell Death Caused by Oxidative Glutamate Toxicity.", "Abstract": {"AbstractText": ["Oxidative stress is one of the main causes of brain cell death in neurological disorders. The use of natural antioxidants to maintain redox homeostasis contributes to alleviating neurodegeneration. Glutamate is an excitatory neurotransmitter that plays a critical role in many brain functions. However, excessive glutamate release induces excitotoxicity and oxidative stress, leading to programmed cell death. Our study aimed to evaluate the effect of osmundacetone (OAC), isolated from <i>Elsholtzia ciliata</i> (Thunb.) Hylander, against glutamate-induced oxidative toxicity in HT22 hippocampal cells. The effect of OAC treatment on excess reactive oxygen species (ROS), intracellular calcium levels, chromatin condensation, apoptosis, and the expression level of oxidative stress-related proteins was evaluated. OAC showed a neuroprotective effect against glutamate toxicity at a concentration of 2 \u03bcM. By diminishing the accumulation of ROS, as well as stimulating the expression of heat shock protein 70 (HSP70) and heme oxygenase-1 (HO-1), OAC triggered the self-defense mechanism in neuronal cells. The anti-apoptotic effect of OAC was demonstrated through its inhibition of chromatin condensation, calcium accumulation, and reduction of apoptotic cells. OAC significantly suppressed the phosphorylation of mitogen-activated protein kinases (MAPKs), including c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 kinases. Thus, OAC could be a potential agent for supportive treatment of neurodegenerative diseases."]}, "AuthorList": [{"Identifier": ["0000-0001-7439-6245"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Saigon Pharmaceutical Science and Technology Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh 70000, Vietnam."}], "LastName": "Trinh", "ForeName": "Tuy An", "Initials": "TA"}, {"Identifier": ["0000-0002-2672-212X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine (KIOM), Naju 58245, Korea."}], "LastName": "Seo", "ForeName": "Young Hye", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Gachon University, Seongnam 13120, Korea."}], "LastName": "Choi", "ForeName": "Sungyoul", "Initials": "S"}, {"Identifier": ["0000-0002-5756-5470"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine (KIOM), Naju 58245, Korea."}], "LastName": "Lee", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Gachon University, Seongnam 13120, Korea."}], "LastName": "Kang", "ForeName": "Ki Sung", "Initials": "KS"}], "GrantList": [{"GrantID": "2019R1F1A1059173", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biphenyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromatin"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radical Scavengers"}, {"RegistryNumber": "0", "NameOfSubstance": "HSP70 Heat-Shock Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ketones"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Picrates"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "osmundacetone"}, {"RegistryNumber": "3KX376GY7L", "NameOfSubstance": "Glutamic Acid"}, {"RegistryNumber": "DFD3H4VGDH", "NameOfSubstance": "1,1-diphenyl-2-picrylhydrazyl"}, {"RegistryNumber": "EC 1.14.14.18", "NameOfSubstance": "Heme Oxygenase-1"}, {"RegistryNumber": "EC 1.14.14.18", "NameOfSubstance": "Hmox1 protein, mouse"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biphenyl Compounds"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium"}, {"QualifierName": [], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Survival"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chromatin"}, {"QualifierName": ["genetics"], "DescriptorName": "Embryophyta"}, {"QualifierName": [], "DescriptorName": "Free Radical Scavengers"}, {"QualifierName": ["metabolism", "toxicity"], "DescriptorName": "Glutamic Acid"}, {"QualifierName": ["metabolism"], "DescriptorName": "HSP70 Heat-Shock Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Heme Oxygenase-1"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ketones"}, {"QualifierName": [], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neurons"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["metabolism"], "DescriptorName": "Oxygen"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Picrates"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO . Neurological Disorders: Public Health Challenges. WHO; Geneva, Switzerland: 2006. pp. 35\u201337."}, {"Citation": "Beghi E., Giussani G., Nichols E., Abd-Allah F., Abdela J., Abdelalim A., Abraha H.N., Adib M.G., Agrawal S., Alahdab F., et al. Global, regional, and national burden of epilepsy, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:357\u2013375. doi: 10.1016/S1474-4422(18)30454-X.", "ArticleIdList": ["10.1016/S1474-4422(18)30454-X", "PMC6416168", "30773428"]}, {"Citation": "WHO . Global Action Plan on the Public Health Response to Dementia 2017\u20132025. World Health Organization; Geneva, Switzerland: 2017."}, {"Citation": "Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094\u20134125. doi: 10.1007/s12035-015-9337-5.", "ArticleIdList": ["10.1007/s12035-015-9337-5", "PMC4937091", "26198567"]}, {"Citation": "Dr\u00f6ge W. Free Radicals in the Physiological Control of Cell Function. Physiol. Rev. 2002;82:47\u201395. doi: 10.1152/physrev.00018.2001.", "ArticleIdList": ["10.1152/physrev.00018.2001", "11773609"]}, {"Citation": "Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;24:1583. doi: 10.3390/molecules24081583.", "ArticleIdList": ["10.3390/molecules24081583", "PMC6514564", "31013638"]}, {"Citation": "Chi H., Chang H.Y., Sang T.K. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases. Int. J. Mol. Sci. 2018;19:3082. doi: 10.3390/ijms19103082.", "ArticleIdList": ["10.3390/ijms19103082", "PMC6213751", "30304824"]}, {"Citation": "Mariani E., Polidori M.C., Cherubini A., Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2005;827:65\u201375. doi: 10.1016/j.jchromb.2005.04.023.", "ArticleIdList": ["10.1016/j.jchromb.2005.04.023", "16183338"]}, {"Citation": "Federico A., Cardaioli E., Da Pozzo P., Formichi P., Gallus G.N., Radi E. Mitochondria, oxidative stress and neurodegeneration. J. Neurol. Sci. 2012;322:254\u2013262. doi: 10.1016/j.jns.2012.05.030.", "ArticleIdList": ["10.1016/j.jns.2012.05.030", "22669122"]}, {"Citation": "Radi E., Formichi P., Battisti C., Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J. Alzheimers Dis. 2014;42:S125\u2013S152. doi: 10.3233/JAD-132738.", "ArticleIdList": ["10.3233/JAD-132738", "25056458"]}, {"Citation": "Desnuelle C., Dib M., Garrel C., Favier A. A Double-Blind, Placebo-Controlled Randomized Clinical Trial of Alpha-Tocopherol (Vitamin E) in the Treatment of Amyotrophic Lateral Sclerosis. ALS Riluzole-Tocopherol Study Group. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2001;2:9\u201318. doi: 10.1080/146608201300079364.", "ArticleIdList": ["10.1080/146608201300079364", "11465936"]}, {"Citation": "Arlt S., Muller-Thomsen T., Beisiegel U., Kontush A. Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer\u2019s disease. Neurochem. Res. 2012;37:2706\u20132714. doi: 10.1007/s11064-012-0860-8.", "ArticleIdList": ["10.1007/s11064-012-0860-8", "22878647"]}, {"Citation": "Gubandru M., Margina D., Tsitsimpikou C., Goutzourelas N., Tsarouhas K., Ilie M., Tsatsakis A.M., Kouretas D. Alzheimer\u2019s disease treated patients showed different patterns for oxidative stress and inflammation markers. Food Chem. Toxicol. 2013;61:209\u2013214. doi: 10.1016/j.fct.2013.07.013.", "ArticleIdList": ["10.1016/j.fct.2013.07.013", "23871825"]}, {"Citation": "Snalina N., Alessenko A., Gavrilova S., Gurianova S., Prochorov A., Kononova E., Fedorova Y. Memantine changes lipids spectrum and lipid peroxidation in animal brain and plasma of patients with Alzheimer\u2019s disease. FEBS J. 2014;281:65\u2013784. doi: 10.1111/febs.12919.", "ArticleIdList": ["10.1111/febs.12919"]}, {"Citation": "Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J. Neurochem. 1984;42:1\u201311. doi: 10.1111/j.1471-4159.1984.tb09689.x.", "ArticleIdList": ["10.1111/j.1471-4159.1984.tb09689.x", "6139418"]}, {"Citation": "Tapiero H., Mathe G., Couvreur P., Tew K.D., II. Glutamine and glutamate. Biomed. Pharmacother. 2002;56:446\u2013457. doi: 10.1016/S0753-3322(02)00285-8.", "ArticleIdList": ["10.1016/S0753-3322(02)00285-8", "12481981"]}, {"Citation": "Herrera F., Sainz R.M., Mayo J.C., Mart\u00edn V., Antol\u00edn I., Rodriguez C. Glutamate induces oxidative stress not mediated by glutamate receptors or cystine transporters: Protective effect of melatonin and other antioxidants. J. Pineal. Res. 2001;31:356\u2013362. doi: 10.1034/j.1600-079X.2001.310411.x.", "ArticleIdList": ["10.1034/j.1600-079X.2001.310411.x", "11703566"]}, {"Citation": "McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 1985;312:159\u2013163. doi: 10.1056/NEJM198501173120305.", "ArticleIdList": ["10.1056/NEJM198501173120305", "2981404"]}, {"Citation": "Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann. Neurol. 1992;32:297\u2013311. doi: 10.1002/ana.410320302.", "ArticleIdList": ["10.1002/ana.410320302", "1384420"]}, {"Citation": "Dumuis A., Sebben M., Haynes L., Pin J.P., Bockaert J. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature. 1988;336:68\u201370. doi: 10.1038/336068a0.", "ArticleIdList": ["10.1038/336068a0", "2847054"]}, {"Citation": "Bannai S., Kitamura E. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 1980;255:2372\u20132376. doi: 10.1016/S0021-9258(19)85901-X.", "ArticleIdList": ["10.1016/S0021-9258(19)85901-X", "7358676"]}, {"Citation": "Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623\u2013634. doi: 10.1016/0896-6273(88)90162-6.", "ArticleIdList": ["10.1016/0896-6273(88)90162-6", "2908446"]}, {"Citation": "Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525\u2013542. doi: 10.1007/s00424-010-0809-1.", "ArticleIdList": ["10.1007/s00424-010-0809-1", "20229265"]}, {"Citation": "Kritis A.A., Stamoula E.G., Paniskaki K.A., Vavilis T.D. Researching glutamate\u2014Induced cytotoxicity in different cell lines: A comparative/collective analysis/study. Front. Cell. Neurosci. 2015;9:91. doi: 10.3389/fncel.2015.00091.", "ArticleIdList": ["10.3389/fncel.2015.00091", "PMC4362409", "25852482"]}, {"Citation": "Ravindran P.N. The Encyclopedia of Herbs and Spices. CABI; Wallingford, UK: 2017."}, {"Citation": "Yip L., Hudson J.B., Towers G.N. Towers GH. Isolation of the anthropogenic compound fluoranthene in a screening of Chinese medicinal plants for antiviral compounds. Planta Med. 1995;61:187\u2013188. doi: 10.1055/s-2006-958047.", "ArticleIdList": ["10.1055/s-2006-958047", "7753931"]}, {"Citation": "Liu X., Jia J., Yang L., Yang F., Ge H., Zhao C., Zhang L., Zu Y. Evaluation of antioxidant activities of aqueous extracts and fractionation of different parts of Elsholtzia ciliata. Molecules. 2012;17:5430\u20135441. doi: 10.3390/molecules17055430.", "ArticleIdList": ["10.3390/molecules17055430", "PMC6268047", "22572928"]}, {"Citation": "Pudziuvelyte L., Liaudanskas M., Jekabsone A., Sadauskiene I., Bernatoniene J. Elsholtzia ciliata (Thunb.) Hyl. Extracts from Different Plant Parts: Phenolic Composition, Antioxidant, and Anti-Inflammatory Activities. Molecules. 2020;25:1153. doi: 10.3390/molecules25051153.", "ArticleIdList": ["10.3390/molecules25051153", "PMC7179165", "32150805"]}, {"Citation": "Kim H.H., Yoo J.S., Lee H.S., Kwon T.K., Shin T.Y., Kim S.H. Elsholtzia ciliata inhibits mast cell-mediated allergic inflammation: Role of calcium, p38 mitogen-activated protein kinase and nuclear factor-{kappa}B. Exp. Biol. Med. (Maywood) 2011;236:1070\u20131077. doi: 10.1258/ebm.2011.011017.", "ArticleIdList": ["10.1258/ebm.2011.011017", "21807818"]}, {"Citation": "Kim T.W., Kim Y.J., Seo C.S., Kim H.T., Park S.R., Lee M.Y., Jung J.Y. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ss and Smad3 expression on unilateral ureteral obstruction rat model. Phytomedicine. 2016;23:331\u2013339. doi: 10.1016/j.phymed.2016.01.013.", "ArticleIdList": ["10.1016/j.phymed.2016.01.013", "27002403"]}, {"Citation": "Le T.B., Beaufay C., Nghiem D.T., Mingeot-Leclercq M.P., Quetin-Leclercq J. In Vitro Anti-Leishmanial Activity of Essential Oils Extracted from Vietnamese Plants. Molecules. 2017;22:1071. doi: 10.3390/molecules22071071.", "ArticleIdList": ["10.3390/molecules22071071", "PMC6152080", "28654013"]}, {"Citation": "Nugroho A., Park J.H., Choi J.S., Park K.S., Hong J.P., Park H.J. Structure determination and quantification of a new flavone glycoside with anti-acetylcholinesterase activity from the herbs of Elsholtzia ciliata. Nat. Prod. Res. 2019;33:814\u2013821. doi: 10.1080/14786419.2017.1413556.", "ArticleIdList": ["10.1080/14786419.2017.1413556", "29224362"]}, {"Citation": "Choi M.S., Choi B.S., Kim S.H., Pak S.C., Jang C.H., Chin Y.W., Kim Y.M., Kim D.I., Jeon S., Koo B.S. Essential Oils from the Medicinal Herbs Upregulate Dopamine Transporter in Rat Pheochromocytoma Cells. J. Med. Food. 2015;18:1112\u20131120. doi: 10.1089/jmf.2015.3475.", "ArticleIdList": ["10.1089/jmf.2015.3475", "26295793"]}, {"Citation": "Lee M.S., Hwang B.S., Lee I.K., Seo G.S., Yun B.S. Chemical Constituents of the Culture Broth of Phellinus linteus and Their Antioxidant Activity. Mycobiology. 2015;43:43\u201348. doi: 10.5941/MYCO.2015.43.1.43.", "ArticleIdList": ["10.5941/MYCO.2015.43.1.43", "PMC4397379", "25892914"]}, {"Citation": "Hwang B.S., Lee M.S., Lee S.W., Lee I.K., Seo G.S., Choi H.J., Yun B.S. Neuraminidase Inhibitors from the Fermentation Broth of Phellinus linteus. Mycobiology. 2014;42:189\u2013192. doi: 10.5941/MYCO.2014.42.2.189.", "ArticleIdList": ["10.5941/MYCO.2014.42.2.189", "PMC4112237", "25071390"]}, {"Citation": "Chao W., Deng J.S., Huang S.S., Li P.Y., Liang Y.C., Huang G.J. 3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways. Int. Immunopharmacol. 2017;50:77\u201386. doi: 10.1016/j.intimp.2017.06.014.", "ArticleIdList": ["10.1016/j.intimp.2017.06.014", "28644965"]}, {"Citation": "Kim J.H., Kwon H.J., Kim B.W. Protective Effect of 4-(3,4-Dihydroxyphenyl)-3-Buten-2-One from Phellinus linteus on Naproxen-Induced Gastric Antral Ulcers in Rats. J. Microbiol. Biotechnol. 2016;26:823\u2013828. doi: 10.4014/jmb.1511.11024.", "ArticleIdList": ["10.4014/jmb.1511.11024", "26767575"]}, {"Citation": "Gunjima K., Tomiyama R., Takakura K., Yamada T., Hashida K., Nakamura Y., Konishi T., Matsugo S., Hori O. 3,4-dihydroxybenzalacetone protects against Parkinson\u2019s disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway. J. Cell. Biochem. 2014;115:151\u2013160. doi: 10.1002/jcb.24643.", "ArticleIdList": ["10.1002/jcb.24643", "23959789"]}, {"Citation": "Tomiyama R., Takakura K., Takatou S., Le T.M., Nishiuchi T., Nakamura Y., Konishi T., Matsugo S., Hori O. 3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester induce preconditioning ER stress and autophagy in SH-SY5Y cells. J. Cell. Physiol. 2018;233:1671\u20131684. doi: 10.1002/jcp.26080.", "ArticleIdList": ["10.1002/jcp.26080", "28681934"]}, {"Citation": "Maher P., van Leyen K., Dey P.N., Honrath B., Dolga A., Methner A. The role of Ca(2+) in cell death caused by oxidative glutamate toxicity and ferroptosis. Cell Calcium. 2018;70:47\u201355. doi: 10.1016/j.ceca.2017.05.007.", "ArticleIdList": ["10.1016/j.ceca.2017.05.007", "PMC5682235", "28545724"]}, {"Citation": "Zhang Y., Bhavnani B.R. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci. 2006;7:49. doi: 10.1186/1471-2202-7-49.", "ArticleIdList": ["10.1186/1471-2202-7-49", "PMC1526740", "16776830"]}, {"Citation": "Arakawa M., Ito Y. N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology. Cerebellum. 2007;6:308\u2013314. doi: 10.1080/14734220601142878.", "ArticleIdList": ["10.1080/14734220601142878", "PMC7102236", "17853088"]}, {"Citation": "Tardiolo G., Bramanti P., Mazzon E. Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases. Molecules. 2018;23:3305. doi: 10.3390/molecules23123305.", "ArticleIdList": ["10.3390/molecules23123305", "PMC6320789", "30551603"]}, {"Citation": "Tan S.W.M., Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 2002;71:95\u2013105. doi: 10.1046/j.1471-4159.1998.71010095.x.", "ArticleIdList": ["10.1046/j.1471-4159.1998.71010095.x", "9648855"]}, {"Citation": "Rona G., Giffard M.A.Y. Many mechanisms for Hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 2004;16:53\u201361.", "ArticleIdList": ["14676570"]}, {"Citation": "Loboda A., Damulewicz M., Pyza E., Jozkowicz A., Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell. Mol. Life Sci. 2016;73:3221\u20133247. doi: 10.1007/s00018-016-2223-0.", "ArticleIdList": ["10.1007/s00018-016-2223-0", "PMC4967105", "27100828"]}, {"Citation": "Gary L., Johnson R.L. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911\u20131912.", "ArticleIdList": ["12471242"]}, {"Citation": "Li J.O.W., Li W., Jiang Z.G., Ghanbari H.A. Oxidative stress and neurodegenerative disorders. Int. J. Mol. Sci. 2013;14:24438\u201324475. doi: 10.3390/ijms141224438.", "ArticleIdList": ["10.3390/ijms141224438", "PMC3876121", "24351827"]}, {"Citation": "Son Y., Kim S., Chung H.T., Pae H.O. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 2013;528:27\u201348. doi: 10.1016/B978-0-12-405881-1.00002-1.", "ArticleIdList": ["10.1016/B978-0-12-405881-1.00002-1", "23849857"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "31"}, {"Year": "2021", "Month": "2", "Day": "9"}, {"Year": "2021", "Month": "2", "Day": "18"}, {"Year": "2021", "Month": "3", "Day": "6", "Hour": "1", "Minute": "10"}, {"Year": "2021", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["33671577", "PMC7926874", "10.3390/biom11020328", "biom11020328"]}}], "PubmedBookArticle": []}